MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Clinical and neurological features of the course of parkinsonism in the presence of chronic renal disease

    S. Khudayarova, G. Rakhmatullaeva (Tashkent, Uzbekistan)

  • Clinical and nuclear neuroimaging features of Parkinson’s disease with dysphagia

    K. Ohta, T. Nakajima (Kashiwazaki city Niigata, Japan)

  • Clinical and oculomotor correlates with freezing of gait in Chinese Parkinson’s disease

    W. Chen, L. Wu, L. Zhao, Q. He, C.Y Jiang, Q. Xu, Y.R Dong (Shanghai, China)

  • Clinical and self-reported falls prediction tools in people with Parkinson’s disease

    L. Almeida, H. Meira, M. Piemonte, C. Canning, S. Paul (Salvador, Brazil)

  • Clinical characteristics of pain in Parkinson’s disease dementia

    B. Ciopleias, S. Diaconu, R. Chiujdea, C. Falup-Pecurariu (Braşov, Romania)

  • Clinical characterization and disease progression in spinocerebellar ataxia type 35: A case series

    C. Lin, S. Kuo (New York, NY, USA)

  • Clinical correlation with the Genotype of Friedreich’s Ataxia (FRDA) patients in Indian population

    A.K Srivastava, I. Ahmad, P. Sharma, M. Seth, U. Shamim, I. Singh, R. Rajan, M.P Srivastava, F. Mohammad (New Delhi, India)

  • Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) in Parkinson’s Disease: Longitudinal Results

    J. Gallagher, J. Rick, S. Xie, E. Mamikonyan, B. Deck, S. Rudovsky, A. Chen-Plotkin, N. Dahodwala, J. Morley, J. Duda, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

  • Clinical Effect of Impedance Variations within Normal Limits in Parkinson’s Disease Treated with Subthalamic Deep Brain Stimulation

    A.Y Yilmaz, A. Savas, C. Akbostanci (Ankara, Turkey)

  • Clinical factors associated with neuronal loss in the substantia nigra

    R. Yilmaz, E. Bayram, C. Akbostanci (Ankara, Turkey)

  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 149
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley